Technical analysis of BioXcel Therapeutics, Inc. (BTAI): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
BioXcel Therapeutics, Inc. is a biopharmaceutical firm that has reached the commercial phase, distinguishing itself by leveraging artificial intelligence to advance the creation of transformative therapies in the fields of neuroscience and immuno-oncology.
Price Performance
| 1 month | -94.31% |
| 3 months | -96.24% |
| Year-to-date | -97.18% |
| 1 year | -98.44% |
| 3 years | -99.91% |
| 5 years | -99.99% |
52-Week Range
| 52-week High | $3.95 |
| 52-week Low | $0.02 |
| Avg Volume (90d) | 4.6M |
Technical Indicators
| SMA 50 | $0.79 |
| SMA 200 | $1.32 |
| Beta | 0.30 |
| 30-day Volatility (annualised) | 447.9% |
| Price vs SMA 50 | -94.3% |
| Price vs SMA 200 | -96.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.05 | |
| 2025-11 | $2.25 | +9.8% |
| 2025-12 | $1.60 | -28.9% |
| 2026-01 | $1.59 | -0.6% |
| 2026-02 | $1.67 | +5.0% |
| 2026-03 | $1.34 | -19.8% |
| 2026-04 | $1.23 | -8.2% |
| 2026-05 | $1.17 | -4.9% |
| 2026-06 | $1.41 | +20.5% |
| 2026-07 | $0.81 | -42.7% |
| 2026-08 | $0.16 | -79.9% |
| 2026-09 | $0.05 | -72.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $144M |
| 2026-09-14 | | $898M |
Price
| Price | $0.07 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -0.01 |
| EV / EBITDA | -1.76 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -0.90 |
| Current Ratio | 0.21 |